Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46)
10.1136/bmjdrc-2018-000521
May 29, 2018
Pathophysiology/complications
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
10.1136/bmjdrc-2017-000475
January 30, 2018
Biomarkers of tubulointerstitial damage and function in type 1 diabetes
10.1136/bmjdrc-2017-000461
November 14, 2017
High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case–control study
10.1136/bmjdrc-2017-000393
November 6, 2017
Presentation, pathology and prognosis of renal disease in type 2 diabetes
10.1136/bmjdrc-2017-000412
August 11, 2017
Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy
10.1136/bmjdrc-2017-000408
August 8, 2017
Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
10.1136/bmjdrc-2017-000391
July 7, 2017
Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A1c and treatment modality
10.1136/bmjdrc-2016-000377
May 29, 2017
Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study
10.1136/bmjdrc-2017-000404
May 27, 2017
Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
10.1136/bmjdrc-2016-000352
March 13, 2017